Authors, publication year | Publication type | Geographical location | Study period | Participants (n) | Overall HIV prevalence (measured) %) | Overall prevalence of HIV infection (patient-reported and measured) (%) | Prevalence of new HIV infections (among women accepting testing) (%) | CD4+ <200/mm3 on HIV diagnosis (%) | No or low-grade dysplasia* on HIV diagnosis (%) |
Testing in any grade of cervical dysplasia (no dysplasia, LSIL, HSIL) | |||||||||
Maiman et al, 198840 | Letter | New York, USA | 1988 | 66 | 10.6 | – | – | – | – |
Dottino et al, 199139 | Abstract | New York, USA | 1991 | 116 | 6 | – | – | NA | NA |
Spitzer et al, 199341 | Article | New York, USA | 1990–1991 | 208 | 11.4 | – | 6.1 | – | 68.8 |
Jennings et al, 199642 | Article | New York, USA | 1990–1994 | 1908 | – | – | 3.3 | 11.8 | 74.3 |
Creighton et al, 201243 | Letter | London, UK | 2010–2011 | 687 | – | 2.2 | 0.19 | 0 | 100 |
Testing in patients with HSIL | |||||||||
Rosenvinge et al, 201144 | Abstract | London, UK | 2011 | 829 | – | 1.7 | 0 | NA | NA |
Mosimann et al, 201445 | Article | Lausanne, Switzerland | 2002–2012 | 58 | 1.7 | – | 0 | – | – |
Articles are listed in chronological order of publication.
Created by the authors.
*Cervical intraepithelial neoplasia stage 1 or LSIL.
HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; NA, not applicable.